Osteolytic bone disease is a frequent complication of multiple myeloma ... development of novel drugs for the management of lytic disease in myeloma. Currently, bisphosphonates are the mainstay ...

The team tackled a critical challenge in treating multiple myeloma—a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...

Multiple myeloma (MM) is a type of cancer that affects ... Deep learning techniques have also been applied to improve the detection of lytic bone lesions in CT scans. A study developed a two ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.

Computed tomography (CT) is a sensitive tool for detection of the bone-destructive effects in MM as it can detect small osteolytic lesions ... is a hallmark of multiple myeloma (MM), associated ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...